Teitl: Transforming the treatment of schizophrenia: Design and development of AMPA receptor modulators with a much improved safety profile as novel drugs for treating the cognitive dysfunction associated with schizophrenia and other CNS disorders

Arianwyr
University of Sussex,Wellcome Trust

Prif Ymchwiliwr

Cyd-Ymchwilwyr
Atack, John

Manylion y Prosiect
Gwerth net y ffigur a ddyfarnwyd i Brifysgol Caerdydd: £1,409,355.00
Dyddiad dechrau: 01.08.2017
Dyddiad gorffen: 30.03.2021

Diweddarwyd y tro diwethaf ar 2020-27-05 am 06:13